Healthcare Realty Trust Incorporated (HR)
Official siteREAL ESTATE • REIT - HEALTHCARE FACILITIES • NYSE
Market Cap: $6.71B
Last updated: Nov 17, 2026 at 4:33 PM ET
Healthcare Realty Trust Incorporated (HR) Statistics
Healthcare Realty Trust (HR) has a market cap of $6.71B and a P/FFO of 11.3x on its 2026 FFO estimate. Its dividend yield is 4.99%. Its net debt of $4.23B equals 63.11% of its market cap.
Total Valuation
Enterprise value is 63.11% above the market cap, as debt exceeds cash.
| Market Cap | $6.71B |
|---|---|
| Enterprise Value | $10.94B |
| Latest price (Nov 17, 2026) | $19.25 |
Key Dates
The next earnings report is expected on Feb 10, 2027, covering the quarter ending Dec 31, 2026. The last ex-dividend date was Nov 10, 2026.
| Next Earnings Date | Feb 10, 2027 (expected) |
|---|---|
| Last Earnings Date | Oct 29, 2026 |
| Last Ex-Dividend Date | Nov 10, 2026 |
| Next Payment Date | Nov 20, 2026 |
| Fiscal Year End | December |
Valuation Ratios
P/FFO is 11.3x on the 2026 FFO estimate of $1.70 a share. Its year-end P/S ranged from 4.9x to 12.9x from 2016 to 2025.
| P/FFO (2026 estimate) | 11.3x |
|---|---|
| P/S Ratio | 5.8x |
| Forward P/S | 5.9x |
| P/B Ratio | 1.6x |
| P/TBV Ratio | 1.8x |
| P/FCF Ratio | 40.6x |
| P/OCF Ratio | 14.9x |
Enterprise Valuation
Counting debt and cash, the company is valued at 16.3x EBITDA and 66.8x free cash flow.
| EV / Sales | 9.6x |
|---|---|
| EV / EBITDA | 16.3x |
| EV / EBIT | 80.9x |
| EV / FCF | 66.8x |
Price Statistics
The stock is up 7.35% over 52 weeks and trades 7.00% above its 50-day average.
| Beta (1Y) | 0.13 |
|---|---|
| 52-Week Change | +7.35% |
| 1-Month Change | +13.07% |
| 3-Month Change | +0.90% |
| 6-Month Change | -3.48% |
| 5-Year Change | -44.07% |
| 10-Year Change | -42.02% |
| Total Return (1Y) | +12.70% |
| Total Return (3Y CAGR) | +15.50% |
| Total Return (5Y CAGR) | -1.73% |
| Return vs SPY (1Y) | -4.68% |
| Max Drawdown (1Y) | -21.85% |
| Max Drawdown (3Y) | -24.44% |
| Sharpe Ratio (1Y) | 0.33 |
| Correlation with SPY (1Y) | 0.09 |
| 50-Day Average | $17.99 |
| 200-Day Average | $18.65 |
| 52-Week Range | $15.52 to $21.50 |
| RSI (14 Days) | 64.3 |
| Average Volume (20 Days) | 6.32M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 0.10x current liabilities, and total debt is 1.04x shareholder equity.
| Current Ratio | 0.10x |
|---|---|
| Quick Ratio | 0.10x |
| Debt / Equity | 1.04x |
| Debt / EBITDA | 6.42x |
| Debt / FCF | 26.30x |
| Interest Coverage | 0.73x |
Returns and Efficiency
Return on invested capital is 1.28% over the last 12 months, against a 5-year average of -0.06%.
| Return on Equity (ROE) | -1.11% |
|---|---|
| Return on Assets (ROA) | -0.50% |
| Return on Invested Capital (ROIC) | 1.28% |
| Return on Capital Employed (ROCE) | 1.54% |
| ROE (5Y Average) | -3.73% |
| ROA (5Y Average) | -1.86% |
| ROIC (5Y Average) | -0.06% |
| Asset Turnover | 0.12x |
Scores
HR has a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 6 of 9 |
|---|---|
| Piotroski Strength | Average |
Income Statement
FFO per share was $1.65 for 2025, the latest reported year. Revenue of $1.13B over the last 12 months is down 5.83% from the 12 months before.
| FFO Per Share (2025) | $1.65 |
|---|---|
| Revenue | $1.13B |
| Revenue Growth (YoY) | -5.83% |
| Gross Profit | $710.77M |
| Operating Income | $146.68M |
| Pretax Income | -$45.19M |
| Net Income | -$45.19M |
| EBITDA | $661.92M |
| EBIT | $135.16M |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 45.54% of the $8.96B in total assets.
| Cash and Equivalents | $17.50M |
|---|---|
| Total Debt | $4.25B |
| Net Debt | $4.23B |
| Net Debt Per Share | $12.42 |
| Working Capital | -$159.13M |
| Shareholder Equity | $4.08B |
| Book Value Per Share | $11.98 |
| Tangible Book Value | $3.70B |
| Tangible Book Per Share | $10.87 |
| Total Assets | $8.96B |
| Total Liabilities | $4.83B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $288.13M of capital spending, operating cash flow left $161.55M of free cash flow.
| Operating Cash Flow | $449.69M |
|---|---|
| Capital Expenditures | $288.13M |
| Free Cash Flow | $161.55M |
| FCF Per Share | $0.47 |
| Depreciation and Amortization | $526.77M |
| Dividends Paid | $337.00M |
| Share Repurchases | $229.45M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 12.94%, against a 5-year average of 5.45%.
| Gross Margin | 62.69% |
|---|---|
| Operating Margin | 12.94% |
| Pretax Margin | -3.99% |
| Net Margin | -3.99% |
| EBITDA Margin | 58.38% |
| EBIT Margin | 11.92% |
| FCF Margin | 14.25% |
| Gross Margin (5Y Average) | 62.16% |
| Operating Margin (5Y Average) | 5.45% |
| Net Margin (5Y Average) | -15.53% |
Growth
FFO per share fell 1.94% a year over 3 years, and revenue grew 8.17% a year.
| FFO Per Share Growth (3Y CAGR) | -1.94% |
|---|---|
| Revenue Growth (3Y CAGR) | +8.17% |
| Revenue Growth (5Y CAGR) | +18.76% |
| Book Value Per Share Growth (2Y CAGR) | -14.40% |
| Tangible Book Per Share Growth (2Y CAGR) | -11.36% |
Dividends and Yields
HR pays out 58.18% of 2025 FFO as dividends.
| Dividend Per Share (Annual) | $0.96 |
|---|---|
| Dividend Yield | 4.99% |
| Payment Schedule | Quarterly |
| Dividend Growth (3Y CAGR) | -13.57% |
| Dividend Growth (5Y CAGR) | -12.54% |
| Payout Ratio (2025 FFO) | 58.18% |
| FCF Payout Ratio | 208.60% |
| FFO Yield (2025) | 8.57% |
| FCF Yield | 2.46% |
| Buyback Yield | 3.50% |
| Shareholder Yield | 8.64% |
Peer Position
Against 12 similar companies, HR has the 8th highest P/FFO and the 6th highest P/S.
P/FFOPeer median 12.1x
P/S RatioPeer median 5.5x
ROICPeer median 3.33%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +21.75%
Dividend YieldPeer median 5.87%
| P/FFO | 11.3x vs 12.1x median |
|---|---|
| P/S Ratio | 5.8x vs 5.5x median |
| ROIC | 1.28% vs 3.33% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | -5.83% vs +21.75% median |
| Dividend Yield | 4.99% vs 5.87% median |
Analyst Forecast
FFO per share estimates imply 3.57% growth a year over the next 2 years. Consensus estimates put revenue growth at -0.70% a year over the next 2 fiscal years.
| FFO Per Share Growth Forecast (2Y CAGR) | +3.57% |
|---|---|
| Revenue Growth Forecast (2Y CAGR) | -0.70% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About HR
What is HR's market cap?
Healthcare Realty Trust has a market cap of $6.71B. Its enterprise value, which adds debt and subtracts cash, is $10.94B.
What is HR's price to FFO ratio?
Healthcare Realty Trust has a P/FFO of 11.3x on its 2026 FFO estimate.
How many shares of HR are outstanding?
Healthcare Realty Trust has 340.62M shares outstanding. The count is down 2.67% from a year earlier.
Does HR pay a dividend?
Yes. Healthcare Realty Trust pays $0.96 a share a year, a dividend yield of 4.99%.
How much debt does HR have?
Healthcare Realty Trust has $4.25B of total debt and $17.50M of cash and equivalents, a net debt position of $4.23B.
HR pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors